These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 34377411)

  • 21. Eap1p, a novel eukaryotic translation initiation factor 4E-associated protein in Saccharomyces cerevisiae.
    Cosentino GP; Schmelzle T; Haghighat A; Helliwell SB; Hall MN; Sonenberg N
    Mol Cell Biol; 2000 Jul; 20(13):4604-13. PubMed ID: 10848587
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Design, synthesis and evaluation of analogs of initiation factor 4E (eIF4E) cap-binding antagonist Bn7-GMP.
    Jia Y; Chiu TL; Amin EA; Polunovsky V; Bitterman PB; Wagner CR
    Eur J Med Chem; 2010 Apr; 45(4):1304-13. PubMed ID: 20060622
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biophysical approach to studies of cap-eIF4E interaction by synthetic cap analogs.
    Niedzwiecka A; Stepinski J; Antosiewicz JM; Darzynkiewicz E; Stolarski R
    Methods Enzymol; 2007; 430():209-45. PubMed ID: 17913640
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Eukaryotic Translation Initiation Factor 4E (eIF4E) as a Therapeutic Target for Cancer.
    Karaki S; Andrieu C; Ziouziou H; Rocchi P
    Adv Protein Chem Struct Biol; 2015; 101():1-26. PubMed ID: 26572974
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structural motifs in eIF4G and 4E-BPs modulate their binding to eIF4E to regulate translation initiation in yeast.
    Grüner S; Weber R; Peter D; Chung MY; Igreja C; Valkov E; Izaurralde E
    Nucleic Acids Res; 2018 Jul; 46(13):6893-6908. PubMed ID: 30053226
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeting eukaryotic translation in mesothelioma cells with an eIF4E-specific antisense oligonucleotide.
    Jacobson BA; Thumma SC; Jay-Dixon J; Patel MR; Dubear Kroening K; Kratzke MG; Etchison RG; Konicek BW; Graff JR; Kratzke RA
    PLoS One; 2013; 8(11):e81669. PubMed ID: 24260583
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel N7-Arylmethyl Substituted Dinucleotide mRNA 5' cap Analogs: Synthesis and Evaluation as Modulators of Translation.
    Wojcik R; Baranowski MR; Markiewicz L; Kubacka D; Bednarczyk M; Baran N; Wojtczak A; Sikorski PJ; Zuberek J; Kowalska J; Jemielity J
    Pharmaceutics; 2021 Nov; 13(11):. PubMed ID: 34834356
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Discovery and characterization of conserved binding of eIF4E 1 (CBE1), a eukaryotic translation initiation factor 4E-binding plant protein.
    Patrick RM; Lee JCH; Teetsel JRJ; Yang SH; Choy GS; Browning KS
    J Biol Chem; 2018 Nov; 293(44):17240-17247. PubMed ID: 30213859
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Computational inference of eIF4F complex function and structure in human cancers.
    Wu S; Wagner G
    bioRxiv; 2023 Aug; ():. PubMed ID: 37609226
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structural basis for nematode eIF4E binding an m(2,2,7)G-Cap and its implications for translation initiation.
    Liu W; Jankowska-Anyszka M; Piecyk K; Dickson L; Wallace A; Niedzwiecka A; Stepinski J; Stolarski R; Darzynkiewicz E; Kieft J; Zhao R; Jones DN; Davis RE
    Nucleic Acids Res; 2011 Nov; 39(20):8820-32. PubMed ID: 21965542
    [TBL] [Abstract][Full Text] [Related]  

  • 31. eIF4E activity is regulated at multiple levels.
    Raught B; Gingras AC
    Int J Biochem Cell Biol; 1999 Jan; 31(1):43-57. PubMed ID: 10216943
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel cap analogs for in vitro synthesis of mRNAs with high translational efficiency.
    Grudzien E; Stepinski J; Jankowska-Anyszka M; Stolarski R; Darzynkiewicz E; Rhoads RE
    RNA; 2004 Sep; 10(9):1479-87. PubMed ID: 15317978
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The nematode eukaryotic translation initiation factor 4E/G complex works with a trans-spliced leader stem-loop to enable efficient translation of trimethylguanosine-capped RNAs.
    Wallace A; Filbin ME; Veo B; McFarland C; Stepinski J; Jankowska-Anyszka M; Darzynkiewicz E; Davis RE
    Mol Cell Biol; 2010 Apr; 30(8):1958-70. PubMed ID: 20154140
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Binding of eukaryotic translation initiation factor 4E (eIF4E) to eIF4G represses translation of uncapped mRNA.
    Tarun SZ; Sachs AB
    Mol Cell Biol; 1997 Dec; 17(12):6876-86. PubMed ID: 9372919
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Elevated expression of eukaryotic translation initiation factor 4E is associated with proliferation, invasion and acquired resistance to erlotinib in lung cancer.
    Li Y; Fan S; Koo J; Yue P; Chen ZG; Owonikoko TK; Ramalingam SS; Khuri FR; Sun SY
    Cancer Biol Ther; 2012 Mar; 13(5):272-80. PubMed ID: 22236867
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phenethyl isothiocyanate, a cancer chemopreventive constituent of cruciferous vegetables, inhibits cap-dependent translation by regulating the level and phosphorylation of 4E-BP1.
    Hu J; Straub J; Xiao D; Singh SV; Yang HS; Sonenberg N; Vatsyayan J
    Cancer Res; 2007 Apr; 67(8):3569-73. PubMed ID: 17440067
    [TBL] [Abstract][Full Text] [Related]  

  • 37. mRNA cap analogues substituted in the tetraphosphate chain with CX2: identification of O-to-CCl2 as the first bridging modification that confers resistance to decapping without impairing translation.
    Rydzik AM; Warminski M; Sikorski PJ; Baranowski MR; Walczak S; Kowalska J; Zuberek J; Lukaszewicz M; Nowak E; W Claridge TD; Darzynkiewicz E; Nowotny M; Jemielity J
    Nucleic Acids Res; 2017 Sep; 45(15):8661-8675. PubMed ID: 28666355
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The C-terminal domain of eukaryotic protein synthesis initiation factor (eIF) 4G is sufficient to support cap-independent translation in the absence of eIF4E.
    Ohlmann T; Rau M; Pain VM; Morley SJ
    EMBO J; 1996 Mar; 15(6):1371-82. PubMed ID: 8635470
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Weak binding affinity of human 4EHP for mRNA cap analogs.
    Zuberek J; Kubacka D; Jablonowska A; Jemielity J; Stepinski J; Sonenberg N; Darzynkiewicz E
    RNA; 2007 May; 13(5):691-7. PubMed ID: 17369309
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activation of EIF4E by Aurora Kinase A Depicts a Novel Druggable Axis in Everolimus-Resistant Cancer Cells.
    Katsha A; Wang L; Arras J; Omar OM; Ecsedy J; Belkhiri A; El-Rifai W
    Clin Cancer Res; 2017 Jul; 23(14):3756-3768. PubMed ID: 28073841
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.